Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface

Autoimmunity

Volumn 48, Issue 5, 2015, Pages 328-335

  Nagata, Keiko ^a   Nakayama, Yuji ^b   Higaki, Katsumi ^b   Ochi, Marika ^a   Kanai, Kyosuke ^c   Matsushita, Michiko ^a   Kuwamoto, Satoshi ^a   Kato, Masako ^a   Murakami, Ichiro ^a   Iwasaki, Takeshi ^a   Nanba, Eiji ^b   Kimura, Hiroshi ^d   Hayashi, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody disease; Graves; Latent virus; Pathogenesis; Plasma cell differentiation

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; THYROTROPIN RECEPTOR ANTIBODY; AUTOANTIBODY; THYROTROPIN RECEPTOR;

ADULT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL SELECTION; CELL SURFACE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; RADIORECEPTOR ASSAY; SUPERNATANT; VIRUS REACTIVATION; CASE CONTROL STUDY; CELL CULTURE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION; YOUNG ADULT;

ADULT; ANTIBODY FORMATION; AUTOANTIBODIES; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GRAVES DISEASE; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84940559158     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2015.1022163     Document Type: Article

References (22)

1. Kieff, E. D., and A. B. Rickinson. 2006. Epstein-Barr virus and its replication. In Fields Virology, 5th ed. Vol. 2 D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2603-2654.
2. Rickinson, A. B., and E. Kieff. 2006. Epstein-Barr virus. In Fields Virology, 5th ed. Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2655-2700.
3. Davies, P., and T. Larsen. 2007. Thyrotoxicosis. In Williams Textbook of Endocrinology, 11th ed. H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. R. Larsen, eds. Saunders, Philadelphia, PA. p. 333-376.
4. Weetman, A. P., and A. M. McGregor. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15: 788-830.
5. Tomer, Y., and A. Huber. 2009. The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32: 231-239.
6. Tomer, Y., A. Greenberg, G. Barbesino, et al. 2001. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. JCEM. 86: 1687-1693.
7. Ueda, H., J. M. M. Howson, L. Esposito, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
8. Nagata, K., S. Fukata, K. Kanai, et al. 2011. The influence of Epstein-Barr virus reactivation in patients with Graves' disease. Viral Immunol. 24: 143-149.
9. Nagata, K., K. Higaki, Y. Nakayama, et al. 2014. Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals. Autoimmunity 47: 193-200.
10. Crawford, D. H., and I. Ando. 1986. EB virus induction is associated with B-cell maturation. Immunology 59: 405-409.
11. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79: 1296-1307.
12. Frisan, T., V. Levitsky, and M. Masucci. 2001. Generation of lymphoblastoid cell lone (LCLs). In Epstein-Barr Virus Protocols (Method in Molecular Biology), Vol. 174. J. Wilson, and G. H. W. May, eds. Humana Press, Totowa, NJ. p. 125-127.
13. Hinuma, Y., M. Konn, J. Yamaguchi, et al. 1967. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1: 1045-1051.
14. Sairenji, T., and Y. Hinuma. 1980. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Int. J. Cancer 26: 337-342.
15. Sairenji, T., G. Bertoni, M. M. Medveczky, et al. 1988. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/ 220. J. Virol. 62: 2614-2421.
16. Kimura, H., K. Miyake, Y. Yamauchi, et al. 2009. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative disease. J. Infect. Dis. 200: 1073-1087.
17. Hoffman, G. J., S. G. Lazarowits, and S. D. Hayward. 1980. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc. Natl. Acad. Sci. USA 77: 2979-2983.
18. Pellett, P. E., and B. Roizman. 2006. The family Herpesviridae: a brief introduction. In Fields Virology, 5th ed. Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2479-2499
19. Liu, J., J. D. Farmer Jr, W. S. Lane, et al. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.
20. Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 357: 695-697.
21. Chen, C., T. D. Johnston, H. Jeon, et al. 2009. Cyclosporine promotes Epstein-Barr virus-infected human B-cell transformation assayed by three correlated assay methods. Transplant. Proc. 41: 366-370.
22. Bryant, H., and P. J. Farrell. 2002. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76: 10290-10298.